Cybin Inc. (NEO:CYBN)
Canada · Delayed Price · Currency is CAD 8.67
+0.05 (0.58%)
Nov 7, 2025, 3:59 PM EST
Cybin Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
50
Market Cap
232.44M CAD
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | - | - | - |
| Mar 31, 2024 | - | - | - |
| Mar 31, 2023 | - | - | - |
| Mar 31, 2022 | - | - | - |
| Mar 31, 2021 | 686.88K | - | - |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Curaleaf Holdings | 1.78B |
| dentalcorp Holdings | 1.66B |
| Trulieve Cannabis | 1.66B |
| Green Thumb Industries | 1.61B |
| Extendicare | 1.51B |
| WELL Health Technologies | 1.23B |
| Sienna Senior Living | 929.68M |
| Knight Therapeutics | 413.85M |
Cybin News
- 2 days ago - Cybin to Announce Second Quarter Financial Results and Provide Business Update on November 13, 2025 - Business Wire
- 3 days ago - Cybin to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference - Business Wire
- 5 days ago - Cybin to Participate at the 2025 Milken Institute Future of Health Summit - Business Wire
- 8 days ago - Cybin Announces Closing of $175 Million Registered Direct Offering - Business Wire
- 11 days ago - Cybin Announces $175 Million Registered Direct Offering - Business Wire
- 16 days ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cybin Inc. - CYBN - PRNewsWire
- 17 days ago - Cybin: Optimism Quickly Fades - Seeking Alpha
- 18 days ago - BetterLife Pharma Appoints Doug Drysdale as Corporate Advisor - TheNewswire